Reliq Health Technologies Inc V.RHT

Primary Symbol: V.RHT.H Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.

TSXV:RHT.H - Post by User

Reliq Health Technologies Inc

Bullboard Posts

Comment by lscfaon Aug 24, 2020 3:17pm

164 Views

Post# 31447063

RE:For all the glory of this management

I believe one reason the co. may have stopped disclosing onboarding stats is that patient count fluctuates due to patient attrition. Lisa fed us some BS about co-pays being waived for poor patients but waiving co-pays is an exception not the rule. Patients that are paying for part of the monthly service out of their own pocket they may not see the value in continuing the service.

https://hcahealthcare.com/util/forms/ethics/policies/legal/llgen001-a.pdf

Aei773ou wrote: There is one easy way to boost the share price.

Since last February there has been a remarkable accumulation of potential patients through the news contracts achieved by the new business model. I know we have the Covid interruptions to the onboard process. Almost seven months has passed you can’t be serious if you still don’t have an idea as how the sales goes from your partners. You should have been keeping an eye on the revenue that in real will be in the book. The market already anticipates a bad quarter (March - June) by the end of October. However as long as you can resume providing guidance on future revenues this stock should react positively.

Your silence reflects your non-confidence to do so merely validates the market’s scepticism beyond the next six months.